BHARATRAS
Bharat Rasayan Limited
Technical-grade pesticides and agrochemicals manufacturer
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
bharatgroup.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Bharat Rasayan makes pesticides (agrochemicals) at two plants in India and sells them to customers in India and, through exports, to multinational agrochemical companies and traders.
Company snapshot
12thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
What we see
- ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 263 Cr | 233 Cr | 310 Cr | 282 Cr | 328 Cr | 256 Cr | 307 Cr | 377 Cr | 286 Cr | 270 Cr | 308 Cr | 338 Cr |
| Operating expenses (approx.) | 248 Cr | 205 Cr | 240 Cr | 244 Cr | 273 Cr | 215 Cr | 266 Cr | 304 Cr | 253 Cr | 228 Cr | 258 Cr | 287 Cr |
| EBITDA | 15 Cr | 28 Cr | 69 Cr | 38 Cr | 55 Cr | 42 Cr | 40 Cr | 73 Cr | 33 Cr | 43 Cr | 50 Cr | 51 Cr |
| OPM % | 5.5% | 12.0% | 22.4% | 13.5% | 16.7% | 16.3% | 13.1% | 19.4% | 11.6% | 15.8% | 16.3% | 15.0% |
| Other income | 4 Cr | 4 Cr | 11 Cr | 6 Cr | 7 Cr | 7 Cr | 6 Cr | 7 Cr | 9 Cr | 9 Cr | 16 Cr | 6 Cr |
| Interest | 0.53 Cr | 1 Cr | 1 Cr | 0.97 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 0.93 Cr | 1 Cr |
| Depreciation | 6 Cr | 7 Cr | 6 Cr | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 7 Cr |
| Profit before tax | 10 Cr | 22 Cr | 84 Cr | 53 Cr | 46 Cr | 52 Cr | 35 Cr | 54 Cr | 33 Cr | 52 Cr | 51 Cr | 49 Cr |
| Tax % | 39.3% | 29.3% | 20.2% | 18.7% | 29.8% | 21.5% | 27.3% | 26.4% | 25.6% | 22.6% | 25.9% | 23.9% |
| Net profit | 6 Cr | 15 Cr | 67 Cr | 43 Cr | 32 Cr | 41 Cr | 25 Cr | 40 Cr | 24 Cr | 40 Cr | 38 Cr | 37 Cr |
| EPS (₹) | ₹14.44 | ₹36.85 | ₹161.51 | ₹103.77 | ₹77.35 | ₹97.54 | ₹60.48 | ₹95.45 | ₹67.10 | ₹24.08 | ₹22.95 | ₹22.40 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 992 Cr | 1,215 Cr | 1,092 Cr | 1,301 Cr | 1,234 Cr | 1,045 Cr | 1,173 Cr | 1,242 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 805 Cr | 986 Cr | 852 Cr | 1,046 Cr | 1,037 Cr | 927 Cr | 998 Cr | 1,043 Cr | Sign in free for the trailing twelve months |
| EBITDA | 187 Cr | 229 Cr | 240 Cr | 255 Cr | 197 Cr | 117 Cr | 175 Cr | 199 Cr | Sign in free for the trailing twelve months |
| OPM % | 18.9% | 18.9% | 21.9% | 19.6% | 16.0% | 11.2% | 14.9% | 16.0% | Sign in free for the trailing twelve months |
| Other income | 3 Cr | 17 Cr | 7 Cr | 16 Cr | 19 Cr | 21 Cr | 26 Cr | 41 Cr | Sign in free for the trailing twelve months |
| Interest | 16 Cr | 16 Cr | 4 Cr | 7 Cr | 6 Cr | 3 Cr | 5 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Depreciation | 17 Cr | 22 Cr | 26 Cr | 25 Cr | 26 Cr | 26 Cr | 27 Cr | 26 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 155 Cr | 205 Cr | 215 Cr | 234 Cr | 174 Cr | 123 Cr | 185 Cr | 193 Cr | Sign in free for the trailing twelve months |
| Tax % | 28.1% | 23.2% | 23.9% | 24.7% | 28.4% | 22.6% | 23.8% | 24.6% | Sign in free for the trailing twelve months |
| Net profit | 112 Cr | 158 Cr | 164 Cr | 176 Cr | 125 Cr | 96 Cr | 141 Cr | 146 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹262.49 | ₹371.03 | ₹385.72 | ₹423.52 | ₹299.89 | ₹229.86 | ₹339.14 | ₹87.67 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | 0.4% | 0.4% | 0.5% | 0.7% | 0.4% | 0.4% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 8 Cr |
| Reserves | 405 Cr | 560 Cr | 723 Cr | 766 Cr | 889 Cr | 984 Cr | 1,126 Cr | 1,266 Cr |
| Borrowings | 247 Cr | 94 Cr | 58 Cr | 174 Cr | 28 Cr | 80 Cr | 85 Cr | 1 Cr |
| Other liabilities | 100 Cr | 94 Cr | 122 Cr | 146 Cr | 152 Cr | 129 Cr | 193 Cr | 157 Cr |
| Total liabilities | 756 Cr | 752 Cr | 908 Cr | 1,090 Cr | 1,074 Cr | 1,197 Cr | 1,408 Cr | 1,433 Cr |
| Fixed assets (net) | 149 Cr | 203 Cr | 191 Cr | 228 Cr | 224 Cr | 230 Cr | 229 Cr | 246 Cr |
| CWIP | 35 Cr | 18 Cr | 18 Cr | 11 Cr | 11 Cr | 6 Cr | 15 Cr | 46 Cr |
| Investments | 0.09 Cr | 9 Cr | 150 Cr | 43 Cr | 67 Cr | 143 Cr | 298 Cr | 324 Cr |
| Inventories | 210 Cr | 160 Cr | 169 Cr | 277 Cr | 323 Cr | 267 Cr | 290 Cr | 331 Cr |
| Trade receivables | 279 Cr | 251 Cr | 296 Cr | 464 Cr | 325 Cr | 394 Cr | 419 Cr | 385 Cr |
| Cash & bank | 6 Cr | 46 Cr | 27 Cr | 0.33 Cr | 19 Cr | 32 Cr | 55 Cr | 23 Cr |
| Other assets | 76 Cr | 65 Cr | 58 Cr | 66 Cr | 105 Cr | 125 Cr | 100 Cr | 78 Cr |
| Total assets | 756 Cr | 752 Cr | 908 Cr | 1,090 Cr | 1,074 Cr | 1,197 Cr | 1,408 Cr | 1,433 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | -52 Cr | 263 Cr | 170 Cr | -65 Cr | 213 Cr | 41 Cr | 172 Cr | 132 Cr |
| Cash from investing | -48 Cr | -68 Cr | -153 Cr | 51 Cr | -61 Cr | -90 Cr | -157 Cr | -96 Cr |
| Cash from financing | 102 Cr | -169 Cr | -40 Cr | -25 Cr | -152 Cr | 49 Cr | -0.59 Cr | -89 Cr |
| Net cash flow | 4 Cr | 40 Cr | -19 Cr | -26 Cr | 1 Cr | 14 Cr | 23 Cr | -33 Cr |
| Free cash flow (OCF − Capex) | -100 Cr | 204 Cr | 140 Cr | -121 Cr | 190 Cr | 14 Cr | 136 Cr | 59 Cr |
Ratios
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 26.1% | 33.6% | 27.9% | 25.5% | 19.5% | 11.8% | 15.6% | 15.5% |
| ROE % | 27.3% | 27.9% | 22.5% | 22.9% | 13.9% | 9.7% | 12.5% | 11.4% |
| Debtor days | 102 | 75 | 99 | 130 | 96 | 138 | 130 | 113 |
| Inventory days | 106 | 74 | 92 | 109 | 138 | 144 | 128 | 151 |
| Days payable | 22 | 18 | 34 | 27 | 32 | 39 | 63 | 44 |
| Cash conversion cycle | 186 | 131 | 157 | 212 | 202 | 242 | 196 | 219 |
| OCF / EBITDA % | -28.0% | 114.6% | 71.1% | -25.7% | 108.1% | 35.0% | 98.4% | 66.3% |
| OCF / EBITDA % (3 years) | — | — | 58.0% | 50.8% | 46.0% | 33.2% | 87.1% | 70.2% |
| Debt / equity | 0.60 | 0.17 | 0.08 | 0.23 | 0.03 | 0.08 | 0.08 | 0.0010 |
| Current ratio | 1.92 | 3.38 | 3.82 | 2.59 | 4.64 | 4.60 | 4.19 | 7.78 |
| Net debt / EBITDA | 1.29 | — | — | — | 0.05 | 0.41 | 0.17 | -0.11 |